Allergic contact dermatitis can occur (may manifest as failure to heal). Development of Kaposi’s sarcoma with prolonged treatment (case reports) with corticosteroids. Adverse systemic effects including Cushing’s syndrome, hyperglycemia, glycosuria, fluid and electrolyte changes, and reversible HPA axis suppression (particularly in younger children) may occur when used on large surface areas, for prolonged periods, or with an occlusive dressing and/or concurrently with other corticosteroid-containing preparations. Chronic use of corticosteroids in children may interfere with growth and development. Children are at greater risk of glucocorticoid insufficiency during and/or after withdrawal of treatment. Intracranial hypertension has occurred in children. Striae reported in children treated inappropriately with topical corticosteroids. For dermatologic use only. Not for oral or intravaginal use. Prolonged use of topical corticosteroids may cause atrophy of the epidermis and subcutaneous tissue mostly in intertriginous (e.g. axilla, groin), flexor, and facial areas. Avoid using occlusive dressings on weeping or exudative lesions.